Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Old API Wind-down Ltd - Ordinary Shares ARLZQ

Healthcare Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently operates in two geographical markets, the United States and Canada. The firm generates most of its reven


OTCPK:ARLZQ - Post by User

Old API Wind-down Ltd - Ordinary Shares
Bullboard Posts
User Avatar Image
(0)
•••
Comment by clestoron Mar 19, 2013 9:27pm
179 Views
Post# 21153323

RE: RE: RE: Firday hearing

RE: RE: RE: Firday hearing

Washplant - If more ARZ shareholders withdraw their tender from AGI, then maybe AGI will go ahead and raise their offer.  They probably think they can block the HL vote and simply outlast HL.  But, I want a higher price from AGI . . .  and they can certainly afford it.  AGI has been attempting discussions with ARZ for over a year and they definitely have synergies with ARZ, so I think they will be disappointed if they don't close the deal.

Today AGI shares were up.  But, ARZ was also up and the discount to HL's offer narrowed.  Could be coincidence, but looks to me as if investors think the HL deal is going to close so that spread narrowed to 2%ish (vs 5.4% to AGI's offer).  AGI price was up because the risk of dilution seems less . . .

Anyone have other thoughts?

GLTA

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities